A prospetctive observational study to elucidate the safty and efficacy of GLP-1 analogue treatment for non-alcoholic steatohepatitis patients with type2 diabetes mellitus
Not Applicable
Recruiting
- Conditions
- ASH patients with type2 diabetes mellitus who have indication for GLP-1 analogue treatment.
- Registration Number
- JPRN-UMIN000004512
- Lead Sponsor
- Mitsui Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patinets who have history of HBV or HCV infection, and auto-immune hepatitis. 2.Patients who take alcohol more than 20g/day as 100% ethanol. 3.Patients who have renal dysfunction (Cre over 2.0 mg/dl or eGFR less than 30 mL/min). 4.Patients who have platelet counts less than 50,000/micro-litter or prothrombin activity less than 50%. 5.Patients who have history of pancreatitis. 6.Patients who are treated with other clinical trial medicine. 7.Patients who have malignancy. 8.Patients who are judged no indication by whome resposible for this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Imprpvment of the value of transaminase and NAFLD activity score.
- Secondary Outcome Measures
Name Time Method Imprpvment of the value of fasting blood sugar, HbA1c, and fasting blood concentration of insulin. Imprpvment of body weight, visveral fat areas, and fatty liver.